Abstract
While stroke rates associated with TAVR have improved over time stroke remains a significant persistent complication. The Sentinel device was aaproved for cerebral embolic protection during TAVR but its clinical efficacy remains uncertain, concerns remain as to potential complications, cost, and
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
